Literature DB >> 33675129

MiR-873-5p modulates progression of tongue squamous cell carcinoma via targeting SEC11A.

Yao Yao1, Xiao-Qin Liu1, Feng-Ying Yang2, Jing-Wen Mu2.   

Abstract

OBJECTIVE: To explore the effect of miR-873-5p on proliferation, apoptosis, migration, and invasion of tongue squamous cell carcinoma (TSCC) by targeting SEC11A.
METHODS: Tongue squamous cell carcinoma tissues were collected and performed by qRT-PCR and Western blotting to determine the expression of miR-873-5p and SPC18. SCC9 and CAL-27 cells were transfected and divided into Mock, mimic NC, miR-873-5p mimic, SEC11A, and miR-873-5p mimic + SEC11A groups. Then, a series of experiments including cell count kit 8 (CCK-8), wound healing, Transwell, and flow cytometry were conducted. Besides, Western blotting was used to detect the expression of SPC18 and EGFR pathway-related proteins.
RESULTS: MiR-873-5p was downregulated while SPC18 was upregulated in TSCC, and miR-873-5p was negatively correlated with SPC18. Dual luciferase reporter gene assay confirmed SEC11A to be a target of miR-873-5p. Cell proliferation, migration, and invasion of SCC9 and CAL-27 cells in miR-873-5p mimic group were decreased with increased cell apoptosis, presenting with downregulations of SPC18 and EGFR pathway-related proteins, while cells in SEC11A group manifested totally different changes. Moreover, the inhibitory effect of miR-873-5p mimic on TSCC cell growth was abolished by SEC11A overexpression.
CONCLUSION: Overexpression of miR-873-5p may suppress cell proliferation, migration, and invasion, but facilitate apoptosis in TSCC via targeting SEC11A.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  SPC18; miR-873-5p; tongue squamous cell carcinoma

Mesh:

Substances:

Year:  2021        PMID: 33675129     DOI: 10.1111/odi.13830

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   4.068


  2 in total

1.  Comprehensive Analysis of mTORC1 Signaling Pathway-Related Genes in the Prognosis of HNSCC and the Response to Chemotherapy and Immunotherapy.

Authors:  Zhao Ding; Hailong Shen; Ke Xu; Yu Wu; Shuhao Wang; Fangzheng Yi; Daming Wang; Yehai Liu
Journal:  Front Mol Biosci       Date:  2022-04-29

2.  Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.

Authors:  Chunmei Hu; Jiangang Fan; Gang He; Chuan Dong; Shijie Zhou; Yun Zheng
Journal:  PLoS One       Date:  2022-06-02       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.